PH12016500207A1 - Anti-infective compounds - Google Patents
Anti-infective compoundsInfo
- Publication number
- PH12016500207A1 PH12016500207A1 PH12016500207A PH12016500207A PH12016500207A1 PH 12016500207 A1 PH12016500207 A1 PH 12016500207A1 PH 12016500207 A PH12016500207 A PH 12016500207A PH 12016500207 A PH12016500207 A PH 12016500207A PH 12016500207 A1 PH12016500207 A1 PH 12016500207A1
- Authority
- PH
- Philippines
- Prior art keywords
- infective compounds
- compounds
- infective
- treatment
- small molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361861750P | 2013-08-02 | 2013-08-02 | |
| PCT/EP2014/066614 WO2015014993A2 (en) | 2013-08-02 | 2014-08-01 | Anti-infective compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12016500207A1 true PH12016500207A1 (en) | 2016-04-25 |
Family
ID=51260879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12016500207A PH12016500207A1 (en) | 2013-08-02 | 2016-01-29 | Anti-infective compounds |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160185774A1 (https=) |
| EP (1) | EP3027615B1 (https=) |
| JP (3) | JP2016525562A (https=) |
| KR (1) | KR102292293B1 (https=) |
| CN (2) | CN109575018A (https=) |
| DK (1) | DK3027615T3 (https=) |
| ES (1) | ES2883565T3 (https=) |
| HU (1) | HUE056198T2 (https=) |
| PH (1) | PH12016500207A1 (https=) |
| RU (1) | RU2734760C2 (https=) |
| SG (1) | SG11201600686QA (https=) |
| WO (1) | WO2015014993A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA125171C2 (uk) | 2015-07-02 | 2022-01-26 | Янссен Саєнсиз Айрленд Юсі | Антибактеріальні сполуки |
| KR20180053386A (ko) * | 2015-09-17 | 2018-05-21 | 마빈 제이. 밀러 | 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물 |
| JP2019518046A (ja) * | 2016-06-16 | 2019-06-27 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | 抗菌薬としての複素環式化合物 |
| US20200308169A1 (en) | 2016-06-16 | 2020-10-01 | Janssen Sciences Ireland Unlimited Company | Heterocyclic compounds as antibacterials |
| KR20190121315A (ko) | 2017-03-01 | 2019-10-25 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 병용 요법 |
| CN111246848A (zh) * | 2017-10-05 | 2020-06-05 | 快尔生物技术公司 | 与抗结核药物组合的环稠和的噻唑并2-吡啶酮 |
| CN108101828B (zh) * | 2018-01-15 | 2021-05-04 | 西华师范大学 | 3-吲哚基甲酰胺类化合物及其制备方法 |
| CN108159049B (zh) * | 2018-02-01 | 2021-01-05 | 中国科学院广州生物医药与健康研究院 | 一种吡啶类化合物的新用途 |
| WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| JPWO2020203609A1 (https=) * | 2019-03-29 | 2020-10-08 | ||
| JP2022081710A (ja) * | 2019-03-29 | 2022-06-01 | ユーティアイ リミテッド パートナーシップ | 関節リウマチを治療するためのｔ型カルシウムチャネル阻害剤の使用 |
| TWI861208B (zh) * | 2019-09-10 | 2024-11-11 | 日商鹽野義製藥股份有限公司 | 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物 |
| US20220340564A1 (en) | 2019-09-13 | 2022-10-27 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| CN114450288A (zh) * | 2019-09-30 | 2022-05-06 | 爱尔兰詹森科学公司 | 4-喹啉酮抗细菌化合物 |
| MX2022003816A (es) * | 2019-09-30 | 2022-05-06 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| KR102381397B1 (ko) * | 2020-07-10 | 2022-03-30 | 경희대학교 산학협력단 | 신규 나프토퀴논 유도체 화합물 및 이를 포함하는 항균용 조성물 |
| MX2023010947A (es) | 2021-03-16 | 2023-11-29 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| MX2023010941A (es) | 2021-03-17 | 2023-11-28 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| CA3211592A1 (en) | 2021-03-17 | 2022-09-22 | Jerome Emile Georges Guillemont | Antibacterial compounds |
| EP4423097A1 (en) | 2021-10-28 | 2024-09-04 | Janssen Sciences Ireland Unlimited Company | Imidazopyridine amides and related compounds for use in the treatment of bacterial infections |
| JP2025530847A (ja) * | 2022-09-16 | 2025-09-17 | 北京華益健康薬物研究中心 | Ｍｅｔｔｌ３阻害剤化合物、その医薬組成物及び用途 |
| WO2024089170A1 (en) | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| WO2024223859A1 (en) | 2023-04-26 | 2024-10-31 | Janssen Pharmaceutica Nv | Antibacterial compounds |
| KR20260041840A (ko) | 2023-07-18 | 2026-03-27 | 얀센 파마슈티카 엔브이 | 베다퀼린, 프레토마니드 또는 델라마니드, 및 시토크롬 bc1 억제제를 포함하는 적어도 세 가지 항생제의 조합 제품 및 미코박테리아 감염 치료에서의 이들의 용도 |
| CN117946118A (zh) * | 2024-01-15 | 2024-04-30 | 珃诺生物医药科技(杭州)有限公司 | 一种靶向降解erk5蛋白的化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
| US20100298314A1 (en) * | 2006-12-20 | 2010-11-25 | Schering Corporation | Novel jnk inhibitors |
| WO2009140101A2 (en) * | 2008-05-12 | 2009-11-19 | Boehringer Ingelheim International Gmbh | Imidazopyridine compounds useful as mmp-13 inhibitors |
| EP2496578A4 (en) * | 2009-11-05 | 2013-08-21 | Univ Notre Dame Du Lac | IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF |
| SG184073A1 (en) * | 2010-03-18 | 2012-10-30 | Pasteur Institut Korea | Anti-infective compounds |
| KR20140093610A (ko) * | 2011-04-21 | 2014-07-28 | 재단법인 한국파스퇴르연구소 | 소염 화합물 |
| CN103324035B (zh) * | 2013-06-20 | 2015-07-01 | 深圳市华星光电技术有限公司 | 掩膜板和阵列基板的制作方法 |
-
2014
- 2014-08-01 JP JP2016530547A patent/JP2016525562A/ja not_active Withdrawn
- 2014-08-01 US US14/909,663 patent/US20160185774A1/en not_active Abandoned
- 2014-08-01 WO PCT/EP2014/066614 patent/WO2015014993A2/en not_active Ceased
- 2014-08-01 CN CN201811384685.9A patent/CN109575018A/zh active Pending
- 2014-08-01 CN CN201480054331.1A patent/CN105745208A/zh active Pending
- 2014-08-01 RU RU2016107378A patent/RU2734760C2/ru active
- 2014-08-01 SG SG11201600686QA patent/SG11201600686QA/en unknown
- 2014-08-01 ES ES14745158T patent/ES2883565T3/es active Active
- 2014-08-01 HU HUE14745158A patent/HUE056198T2/hu unknown
- 2014-08-01 KR KR1020167005457A patent/KR102292293B1/ko active Active
- 2014-08-01 DK DK14745158.7T patent/DK3027615T3/da active
- 2014-08-01 EP EP14745158.7A patent/EP3027615B1/en active Active
-
2016
- 2016-01-29 PH PH12016500207A patent/PH12016500207A1/en unknown
-
2018
- 2018-06-25 JP JP2018119810A patent/JP6757768B2/ja active Active
-
2019
- 2019-04-15 JP JP2019077088A patent/JP2019131606A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2883565T3 (es) | 2021-12-09 |
| EP3027615B1 (en) | 2021-07-21 |
| SG11201600686QA (en) | 2016-02-26 |
| RU2734760C2 (ru) | 2020-10-23 |
| KR20170082450A (ko) | 2017-07-14 |
| DK3027615T3 (da) | 2021-10-25 |
| JP6757768B2 (ja) | 2020-09-23 |
| WO2015014993A3 (en) | 2015-04-02 |
| JP2018158941A (ja) | 2018-10-11 |
| CN105745208A (zh) | 2016-07-06 |
| KR102292293B1 (ko) | 2021-08-23 |
| WO2015014993A2 (en) | 2015-02-05 |
| HUE056198T2 (hu) | 2022-02-28 |
| US20160185774A1 (en) | 2016-06-30 |
| CN109575018A (zh) | 2019-04-05 |
| RU2016107378A3 (https=) | 2018-03-29 |
| RU2016107378A (ru) | 2017-09-07 |
| JP2019131606A (ja) | 2019-08-08 |
| EP3027615A2 (en) | 2016-06-08 |
| JP2016525562A (ja) | 2016-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500207A1 (en) | Anti-infective compounds | |
| PH12012501841B1 (en) | Anti-infective compounds | |
| PH12016502436A1 (en) | Anti-infective compounds | |
| ZA201708692B (en) | Antibacterial compounds | |
| PH12016501099A1 (en) | Materials and methods for controlling infections | |
| PH12016501512B1 (en) | Treatment for resistant acne | |
| PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
| IL242770B (en) | A therapeutic combination that includes oxazolidinone-quinolones for use in the treatment of bacterial infections | |
| CL2015003019A1 (es) | Derivados biaromáticos antibacterianos | |
| MX352760B (es) | Metodos para tratar infecciones intrapulmonares. | |
| MX2015009818A (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple. | |
| ZA201503474B (en) | Compositions and methods for treating bacterial infections | |
| IN2013MU03216A (https=) | ||
| EA201590615A1 (ru) | Стимулирующие лактацию композиции на основе фосфатидилсерина | |
| MX356102B (es) | Compuestos y métodos para tratar leucemia. | |
| MX2015014657A (es) | Nuevos agentes antibacterianos de fenicol. | |
| EA201690709A1 (ru) | Применение одипарцила в лечении мукополисахаридоза | |
| IN2013MU01983A (https=) | ||
| TR201314933A2 (tr) | Bakteriyel enfeksiyonların tedavisine yönelik bir kompozisyon. | |
| AU2013900412A0 (en) | Methods Of Treating Microbial Infections, Including Skin Infections | |
| AU2013901517A0 (en) | Methods of Treating Bacterial Infections | |
| TH149195A (th) | สารประกอบซึ่งต้านการติดเชื้อ | |
| TH1401003659A (th) | ไนฟูราเทลซัลฟอกไซด์สำหรับการใช้ในการรักษาการติดเชื้อแบคทีเรีย | |
| TH1401006729A (th) | (r)-ไนฟิวราเทล, การใช้ของมันสำหรับการรักษาการติดเชื้อ และการสังเคราะห์ (r) และ (s)-ไนฟิวราเทล |